Humana (HUM) Operating Income (2009 - 2026)

Humana (HUM) has reported Operating Income for 18 consecutive years, with $1.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Income rose 23.86% year-over-year to $1.4 billion in Q2 2026; TTM through Jun 2026 was $2.7 billion, a 17.93% decrease from a year earlier, with the FY2025 full-year figure at $2.7 billion, up 5.54% from the prior year.
• Operating Income was $1.4 billion for Q2 2026 at Humana, down from $1.8 billion in the prior quarter.
• Over five years, Operating Income peaked at $2.0 billion in Q1 2025 and troughed at -$808.0 million in Q4 2025.
• A 5-year average of $899.6 million and a median of $1.2 billion in 2022 frame the typical range for Operating Income.
• Across the five-year window, Operating Income jumped 103.28% in 2022 and slumped 380.65% in 2023, its largest moves.
• Over 5 years, Operating Income stood at $124.0 million in 2022, then tumbled by 380.65% to -$348.0 million in 2023, then plunged by 56.03% to -$543.0 million in 2024, then tumbled by 48.8% to -$808.0 million in 2025, then soared by 268.32% to $1.4 billion in 2026.
• The last three Operating Income figures came in at $1.4 billion (Q2 2026), $1.8 billion (Q1 2026), and -$808.0 million (Q4 2025), per Business Quant data.